Shenzhen tour · Dec 6–11

Apply
How Illuminious Accelerated FDA Approval for a Wearable Diagnostic Tool

How Illuminious Accelerated FDA Approval for a Wearable Diagnostic Tool

Medical/Healthcare

A medical device startup had developed a revolutionary AI-powered continuous ECG monitor but faced two major hurdles: navigating the FDA 510(k) approv...

Walk Shenzhen factories with us, Dec 6–11. See the tour

Medical Device · FDA 510(k) · Wearable · Startup

Share:

Key results

  • 6 Mo EarlyFDA Clearance
  • 10,000+/moProduction
  • SuccessfulMarket Launch

The challenge

A medical device startup had developed a revolutionary AI-powered continuous ECG monitor but faced two major hurdles: navigating the FDA 510(k) approval process and establishing a scalable manufacturing process to meet projected demand.

Our solution

Illuminious provided end-to-end regulatory guidance and implemented a proprietary MES system to digitize and optimize the production line, achieving FDA clearance 6 months ahead of schedule.

Cardio-Innovate, a visionary startup, had developed a revolutionary wearable diagnostic tool poised to transform cardiac care. Their device, an AI-powered continuous ECG monitor, promised early detection of life-threatening cardiac events. However, the path from a working prototype to a market-ready, FDA-approved medical device was fraught with challenges.

The Challenge: From Innovative Concept to Market-Ready Medical Device

The startup faced two major hurdles: navigating the intricate and demanding FDA approval process, and establishing a scalable manufacturing process to meet projected demand.

Regulatory Navigation

Our team of regulatory experts guided Cardio-Innovate through every stage of the FDA 510(k) submission process. This included a comprehensive review of their device's design, software validation, and clinical data to ensure full compliance with all regulatory requirements.

Manufacturing Scalability

We implemented our proprietary Synapse Manufacturing Execution System (MES) to digitize and optimize Cardio-Innovate's production line. This provided real-time visibility and control over the entire manufacturing process, from raw material intake to final product assembly and testing.

6 Months

Ahead of schedule for FDA 510(k) clearance

10,000+

Units produced per month within the first year

Successful

Market launch, establishing Cardio-Innovate as a key player

Partnering with Illuminious was a game-changer for us. Their expertise in both the regulatory and manufacturing aspects of the medical device industry was invaluable. We couldn't have achieved our goals without them.
CEO of Cardio-Innovate

Before Illuminious

  • Uncertain FDA submission timeline (est. 18-24 months)
  • Production capacity of 10 units/month (prototypes)
  • Low market readiness

After Illuminious

  • FDA submission in 12 months
  • Production capacity of 10,000+ units/month
  • High market readiness

Accelerated Time-to-Market

Reduced Regulatory Risk

Scalable & Efficient Manufacturing

Enhanced Product Quality

"Partnering with Illuminious was a game-changer for us. Their expertise in both the regulatory and manufacturing aspects of the medical device industry was invaluable."

Found this case study helpful? Share it:

Ready to achieve similar results?

Let's discuss how we can help your project succeed with our end-to-end manufacturing capabilities.

  1. An engineer runs a free engineering review of your files, and nothing is charged when you submit.
  2. You see the findings first.
  3. We publish the official quote with an itemized total, lead time and validity window.
  4. You accept the official quote, and only then does payment open.